|
 |
FDA Approval Activities for this Drug…
Rescriptor (delavirdine) Tablet, 100 & 200mg Agouron 20-705/S-009 3/14/02 3/29/02 Rescriptor (delavirdine mesylate) Tablet, Agouron NDA 20-705/S-008 5/16/01 7/24/03 5/16/01 Rescriptor (delavirdine mesylate) Tablet, 200mg Pharmacia & Upjohn Company 20-705/S-003 7/14/99 7/28/99 7/28/99 Rescriptor Indication:For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents.
For the most up-to-date approval information, please locate this API using the drug index. |
|
|